Michael Arndt received his Ph.D. in Epidemiology from the University of Washington (UW) in 2016 and has an MPH from UW and a BS in Biology from Duke University. As a doctoral candidate, Michael partnered with icddr,b in Bangladesh to examine fecal biomarkers for Environmental Enteric Dysfunction (EED), a subclinical intestinal disorder related to environmental contamination and intestinal infections. EED appears to be associated with increased risk of stunting and poor vaccine efficacy in children in low and middle income countries. His doctoral research also examined whether a certain hormone may be useful in predicting growth responses to supplemental nutrition among undernourished infants. Michael is currently a post-doctoral fellow with the Drug Development Program at PATH, helping to develop the group’s EED strategy and continuing research with UW faculty and icddr,b related to EED, hormonal responses to feeding, and diarrheagenic E. coli.
Working with a multidisciplinary team of graduate students and faculty members in the START Program helped transform my passion for global health into applicable skills and opened up great opportunities. These challenging and rewarding experiences pushed me to strengthen and utilize my critical thinking, communication, and analytic skills to be successful in a fast-moving, collaborative environment.